{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:39:53Z","timestamp":1767857993128,"version":"3.49.0"},"reference-count":37,"publisher":"CSIRO Publishing","issue":"10","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":2189,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,6]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is an endocrine disorder with a high prevalence in women of childbearing age. To date, there is no method of efficiently diagnosing PCOS and curing it completely because its pathomechanism remains unclear. Here, we investigated whether metabolic abnormalities maintain the hyperandrogenism and PCOS-like ovaries and whether the symptoms induced by excess androgen are treatable. We ceased the abnormal dihydrotestosterone (DHT) stimulation to determine changes in PCOS-like mice. After ceasing DHT stimulation, the ovarian morphology and gene expression recovered from the DHT-stimulated status. However, after cessation of DHT stimulation, the hypertrophy of adipose tissues and hepatic steatosis were not significantly restored, and fat accumulation-related gene expression and serum metabolic markers in the mice were altered. These findings showed that the reproductive dysfunction was obviously relieved, but because the metabolic abnormalities were not relieved after the cessation of excess androgen for 30 days, it appears that the latter may not maintain the former.<\/jats:p>","DOI":"10.1071\/rd18459","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T22:27:26Z","timestamp":1559168846000},"page":"1597-1606","source":"Crossref","is-referenced-by-count":5,"title":["Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice"],"prefix":"10.1071","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-1600","authenticated-orcid":true,"given":"Li-Feng","family":"Sun","sequence":"first","affiliation":[{"name":"AResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China."},{"name":"BUniversity of Chinese Academy of Sciences, Beijing 100049, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Li","family":"Yang","sequence":"additional","affiliation":[{"name":"AResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Xia","family":"Xiao","sequence":"additional","affiliation":[{"name":"AResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Xia","family":"Li","sequence":"additional","affiliation":[{"name":"AResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian V.","family":"Zhang","sequence":"additional","affiliation":[{"name":"AResearch Laboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China."},{"name":"CInstitute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China."},{"name":"DCorresponding author. Email: jian.zhang@siat.ac.cn"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"key":"2025102819551171500_R1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.MCE.2013.01.013","article-title":"Nonhuman primate models of polycystic ovary syndrome.","volume":"373","author":"Abbott","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"2025102819551171500_R2","first-page":"205","article-title":"Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese\/overweight PCOS women under hypocaloric diet.","volume":"15","author":"Amiri","year":"2014","journal-title":"J. Reprod. Infertil."},{"key":"2025102819551171500_R3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/J.FERTNSTERT.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"2025102819551171500_R4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.endonu.2014.01.010","article-title":"Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.","volume":"61","author":"Becerra-Fern\u00e1ndez","year":"2014","journal-title":"Endocrinol. Nutr."},{"key":"2025102819551171500_R5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/S-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.","volume":"25","author":"Blank","year":"2007","journal-title":"Semin. Reprod. Med."},{"key":"2025102819551171500_R6","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1172\/JCI63377","article-title":"Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism.","volume":"122","author":"Brennan-Speranza","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2025102819551171500_R7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/J.CMET.2010.06.010","article-title":"Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor.","volume":"12","author":"Brothers","year":"2010","journal-title":"Cell Metab."},{"key":"2025102819551171500_R8","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/EN.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"issue":"16","key":"2025102819551171500_R9","doi-asserted-by":"publisher","first-page":"E3334","DOI":"10.1073\/PNAS.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2025102819551171500_R10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.FERTNSTERT.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"2025102819551171500_R11","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1128\/MCB.19.5.3760","article-title":"ADD1\/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.","volume":"19","author":"Foretz","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"2025102819551171500_R12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/BF03347020","article-title":"Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.","volume":"26","author":"Gambineri","year":"2003","journal-title":"J. Endocrinol. Invest."},{"key":"2025102819551171500_R13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1385\/ENDO:30:1:27","article-title":"Infertility in polycystic ovary syndrome.","volume":"30","author":"Gorry","year":"2006","journal-title":"Endocrine"},{"key":"2025102819551171500_R14","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.","volume":"101","author":"Horton","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2025102819551171500_R15","doi-asserted-by":"publisher","first-page":"14348","DOI":"10.1073\/PNAS.1507514112","article-title":"Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring.","volume":"112","author":"Hu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102819551171500_R16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1743-7075-9-14","article-title":"Multiple functions of microsomal triglyceride transfer protein.","volume":"9","author":"Hussain","year":"2012","journal-title":"Nutr. Metab. (Lond.)"},{"key":"2025102819551171500_R17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0974-1208.106338","article-title":"Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial.","volume":"5","author":"Kar","year":"2012","journal-title":"J. Hum. Reprod. Sci."},{"key":"2025102819551171500_R18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome.","volume":"6","author":"Karoli","year":"2013","journal-title":"J. Hum. Reprod. Sci."},{"key":"2025102819551171500_R19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1095\/BIOLREPROD.114.120063","article-title":"High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.","volume":"91","author":"Lai","year":"2014","journal-title":"Biol. Reprod."},{"key":"2025102819551171500_R20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1051\/RND:2005010","article-title":"Ovarian effects of a high lactose diet in the female rat.","volume":"45","author":"Liu","year":"2005","journal-title":"Reprod. Nutr. Dev."},{"key":"2025102819551171500_R21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","article-title":"Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.","volume":"30","author":"Lujan","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"2025102819551171500_R22","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1210\/EN.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.","volume":"148","author":"Manner\u00e5s","year":"2007","journal-title":"Endocrinology"},{"key":"2025102819551171500_R23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.EJOGRB.2014.11.008","article-title":"Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome.","volume":"184","author":"Nasiri","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2025102819551171500_R24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MED.0B013E32832AFD4D","article-title":"Androgens and polycystic ovary syndrome.","volume":"16","author":"Nisenblat","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2025102819551171500_R25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.MCE.2012.10.005","article-title":"Sheep models of polycystic ovary syndrome phenotype.","volume":"373","author":"Padmanabhan","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"2025102819551171500_R26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/09513590.2012.754876","article-title":"Ovulatory effects of flutamide in the polycystic ovary syndrome.","volume":"29","author":"Paradisi","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"2025102819551171500_R27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000342179","article-title":"Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.","volume":"40","author":"Pignatelli","year":"2013","journal-title":"Front. Horm. Res."},{"key":"2025102819551171500_R28","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1210\/ENDO.143.8.8961","article-title":"Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase.","volume":"143","author":"Pradeep","year":"2002","journal-title":"Endocrinology"},{"key":"2025102819551171500_R29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/JOE-11-0022","article-title":"The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function.","volume":"209","author":"Radavelli-Bagatini","year":"2011","journal-title":"J. Endocrinol."},{"key":"2025102819551171500_R30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0889-8529(05)70077-3","article-title":"Antiandrogen treatment of polycystic ovary syndrome.","volume":"28","author":"Rittmaster","year":"1999","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2025102819551171500_R31","doi-asserted-by":"publisher","first-page":"D121","DOI":"10.1093\/NAR\/GKX875","article-title":"ICG: a wiki-driven knowledgebase of internal control genes for RT-qPCR normalization.","volume":"46","author":"Sang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2025102819551171500_R32","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1073\/PNAS.0308058101","article-title":"Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder.","volume":"101","author":"Sullivan","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2025102819551171500_R33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.FERTNSTERT.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group.","year":"2004","journal-title":"Fertil. Steril."},{"key":"2025102819551171500_R34","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1210\/EN.2011-1754","article-title":"Reproductive and metabolic phenotype of a mouse model of PCOS.","volume":"153","author":"van Houten","year":"2012","journal-title":"Endocrinology"},{"key":"2025102819551171500_R35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1095\/BIOLREPROD.111.097808","article-title":"Rodent models for human polycystic ovary syndrome.","volume":"86","author":"Walters","year":"2012","journal-title":"Biol. Reprod."},{"key":"2025102819551171500_R36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1074\/JBC.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor ?1 (PPAR?1) overexpression.","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2025102819551171500_R37","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1210\/JC.2003-031292","article-title":"Administration of dihydrotestosterone to rhesus monkeys inhibits gonadotropin-stimulated ovarian steroidogenesis.","volume":"89","author":"Zeleznik","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Reproduction, Fertility and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/rd\/article-pdf\/31\/10\/1597\/313483\/rd18459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/rd\/article-pdf\/31\/10\/1597\/313483\/rd18459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:55:19Z","timestamp":1761695719000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/rd\/article\/31\/10\/1597\/50294\/Removal-of-DHT-can-relieve-polycystic-ovarian-but"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,9,6]]}},"URL":"https:\/\/doi.org\/10.1071\/rd18459","relation":{},"ISSN":["1031-3613","1448-5990"],"issn-type":[{"value":"1031-3613","type":"print"},{"value":"1448-5990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]}}}